Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

GH Research PLC Ordinary Shares (GHRS)

https://www.ghres.com

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/25/2021

Market Cap

504,672,570

Shares Outstanding

52,020,000

Weighted SO

52,020,849

Total Employees

N/A

Upcoming Earnings

08/28/2024

Beta

0.8580

Last Div

0.0000

Range

5.05-14.99

Chg

-0.2000

Avg Vol

46004

Mkt Cap

504672570

Exch

NASDAQ

Country

IE

Phone

353 1 437 8443

DCF Diff

8.1992

DCF

1.5008

Div Yield

0.0000

P/S

6308.4071

EV Multiple

-11.5812

P/FV

2.4061

Div Yield %

0.0000

P/E

-15.6168

PEG

0.0405

Payout

0.0000

Current Ratio

22.0586

Quick Ratio

22.0586

Cash Ratio

10.6506

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

4079.2767

CCC

-4079.2767

Gross Margin

-2.9750

Op Margin

-528.5125

Pretax Margin

-403.9500

Net Margin

-403.9500

Eff Tax Rate

-0.0912

ROA

-0.1485

ROE

-0.1457

ROCE

-0.2010

NI/EBT

1.0000

EBT/EBIT

0.7643

EBIT/Rev

-528.5125

Debt Ratio

0.0041

D/E

0.0043

LT Debt/Cap

0.0027

Total Debt/Cap

0.0043

Int Coverage

-75.0995

CF/Debt

-40.1862

Equity Multi

1.0374

Rec Turnover

0.0000

Pay Turnover

0.0895

Inv Turnover

0.0000

FA Turnover

0.0821

Asset Turnover

0.0004

OCF/Share

-0.6928

FCF/Share

-0.6946

Cash/Share

3.0341

OCF/Sales

-450.5875

FCF/OCF

1.0025

CF Coverage

-40.1862

ST Coverage

-107.2827

CapEx Coverage

-400.5222

Div&CapEx Cov

-400.5222

P/BV

2.4061

P/B

2.4061

P/S

6308.4071

P/E

-15.6168

P/FCF

-13.9655

P/OCF

-14.0004

P/CF

-14.0004

PEG

0.0405

P/S

6308.4071

EV Multiple

-11.5812

P/FV

2.4061

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation